Dyslipidemia is a disorder of lipid metabolism characterized by abnormal levels of serum lipids, including elevated total cholesterol, low-density lipoprotein (LDL), triglycerides, and/or reduced high-density lipoprotein (HDL). It is a major modifiable risk factor for cardiovascular diseases such as coronary artery disease, stroke, and peripheral vascular disease. Clinically, dyslipidemia may remain asymptomatic for long periods, eventually manifesting through complications affecting the heart, brain, and vascular system.

India is witnessing a rapid rise in the prevalence of dyslipidemia due to changing lifestyle patterns, urbanization, unhealthy dietary habits, and reduced physical activity, making it a significant public health concern. Although conventional treatments such as statins and other lipid-lowering agents are effective, long-term therapy is often associated with adverse effects, poor compliance, and economic burden. This highlights the need for exploring safe, effective, and sustainable alternative treatment modalities.

Ayurvedic management of dyslipidemia has shown promising results in improving subjective symptoms and lipid parameters; however, many studies report limitations such as small sample size and lack of comparative evaluation. Therefore, a systematic clinical assessment using appropriate study design is essential to establish evidence-based efficacy.keeping all these facts in mind, it has been decided to conduct a clinical study entitled as" A RANDOMIZED COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF VIDANGADI LAUHA AND TRAYUSHANADI LAUHA WITH PHALATRIKADI KWATH IN  MEDOROGA (DYSLIPIDEMIA)”.